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Abstract
The activity report of the European Network of GMO Laboratories describes the progress made and the work
carried out from the official inauguration of the Network held in Brussels, Belgium, on 4th December 2002
to nowadays. It provides a general overview of the scientific activitites, accomplishments and resources re-
lated to this expert group (in 2004 more than 70 european laboratories are included in the Network under
the chairmanship of the JRC-Biotechnology & GMOs Unit) that has been set up to create a forum for EU and
EEA to collaborate on detection and quantification of GMOs, on sampling and on the development of suit-
able reference materials.
An overview is given of the mission and its implementation, the relations with the outside world and a par-
ticular emphasis is given to the personal experience of participating experts.
Foreword from European Research Commissioner
As Research Commissioner, I have always given high priority to the field of GMOs
and their implications on human and animal health, the environment and the industrial
sector. The promotion of dialogue between research and society and the preparation
and implementation of an EU regulatory framework play key roles in EU policy making
on this topical issue.
Networking plays a pivotal role in the European Research Area and the European
Network of GMO Laboratories (ENGL), with 71 members, is a prime example of a real
success story. The Joint Research Centre played a catalytic role in the establishment of
ENGL and during my inaugural speech on 4 December 2002, I drew attention towards
the need to ascertain a stringent EU regulatory framework for GMOs. Despite the different
thresholds for various commodities and fields of application that such a framework
requires, compliance with complex regulations is now being achieved thanks mostly to this network of top
scientists that develop, improve and validate control methods. It is not surprising that, only months after
its inauguration, the European Network has not only grown in size but it has built up a reputation of
excellence that is being acknowledged by the services of the European Commission and EU industries and
trade partners.
The rather recent nomination of the Joint Research Centre, together with ENGL, as Community Reference
Laboratory again signifies scientific excellence. This is exemplified through its pioneering work on sampling,
certified reference materials, method development and validation and, of course, not forgetting its proactive
role in training young scientists and technicians.
I acknowledge the achievements of ENGL and the Joint Research Centre and I wish its members continued
success during the coming years. I am convinced that this work provides, and will continue to provide, the
backbone for guiding and implementing European Union policies on GMOs.
Philippe Busquin
European Research Commissioner
ENGL inauguration ceremony on 4th December 2002 in the presence
of Europan Research Commissioner Philippe Busquin
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In its function as the EU’s research-based policy support organisation, the Joint Research
Centre (JRC) attaches great importance to underpinning the GMO regulatory framework.
This may be exemplified through:
• The production of the first certified reference materials for GMO tests at
the JRC’s Institute for Reference Materials and Measurement (IRMM) in
Belgium;
• The prospective study of co-existence between traditional, organic and GM
crops at the JRC’s Institute for Prospective Technology (IPTS) in Spain;
• The development, optimisation and validation of analytical methods to
comply with GMO regulations at the JRC’s Institute for Health and Consumer
Protection (IHCP) in Italy.
When member states’ experts met at the JRC in 1999 to discuss the scientific difficulties and challenges
they faced in complying with GMO regulatory requirements, I was aware of the potential strength of this
expert group. So with the backup of Commissioners Busquin and Byrne, I gave my full support to the further
development of what later became known as the European Network of GMO Laboratories (ENGL).
When reading this ENGL activity report, I see that this work reflects the priorities of the JRC. For example,
the nomination of the JRC as Community Reference Laboratory for the GM Food and Feed Regulation will
have far-reaching implications, not only for the JRC and the European Commission, but for the Union as a
whole. ENGL has lined up with the rest of the JRC in placing enormous importance on Enlargement: the
addition of 24 laboratories from the New Member States is highly significant. Also, important advances have
been made on research projects and these in turn have already shown their impact on the regulatory
framework and on European Standardisation. In this respect, I wish to highlight the production of certified
reference materials, the search for alternatives (e.g. plasmids) and the excellent work on sampling. This work
has contributed enormously to legislation on traceability and labelling and is now in the process of becoming
an EU standard.
I am confident that ENGL will continue to impress all stakeholders with its cocktail of expertise, innovation
and excellence and I am convinced that this will foster the development of such networks in other areas. I
congratulate the JRC staff and all members of the ENGL and I wish them all the best in their future work.
Barry Mc Sweeney
Director General JRC
Message from Director General JRC
ENGL inauguration ceremony on 4th December 2002. Director General JRC
Barry McSweeney signs the agreement on behalf of the
European Commission-Joint Research Centre
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It is the intention of the Commissions to develop a competitive European biotechnology
community based on the establishment of a strict regulatory framework on the one hand,
and on building transparency and public confidence on the other. Over the last few
years a number of regulations have been developed that include, for instance, strict
labelling requirements for products that contain living GMOs or their derivatives. It has
turned out that biotechnology companies, as well as control authorities, trade partners
as well as importers have struggled for many years with the analytical implications of
such regulations. Now, with the installation of a strong pan-European network of scientists,
many of those technical issues may be tackled making the regulatory framework more
operational.
In the late nineties, control laboratories throughout Europe have together initiated
discussions and have, under the chairmanship of the European Commissions’ Joint Research Centre, made
an inventory of all technical difficulties that need to be solved in order to be able to meet the expectations
from the consumers, as well as from the biotech producers to establish a transparent and watertight control
system. Today, more than 70 EU control laboratories have joined the “European Network of GMO laboratories”
to work together on harmonized and efficient methods for sampling, on development of reliable methods
for the detection, identification and quantification of GMOs, as well as on the production of reference
materials.
The major activities of ENGL deal with:
• Method development and optimisation, subsequently followed by international validation;
• Proposal of strategies for sampling bulk quantities of seeds, grains, ingredients and food
and feed products for presence of low amounts of GMO’s;
• Development of appropriate reference samples to be included in analytical tests;
• Exchange of data obtained with control activities;
• Develop a molecular database that contains all the sequences of approved and non-EU
approved GMOs with the appropriate interrogation tools.
Members of the ENGL are appointed by EU National Competent Authorities who are responsible for GM
seeds, GM food and GM feed. Norway and Switzerland are also officially involved.
ENGL is chaired by the Institute for Health and Consumer Protection of the Joint Research Centre. As
the chairman I am assisted by a Steering Committee that consists of one representative per Member State.
Decisions are made by consensus.
As a rule of the thumb, two Plenary Sessions and two Steering Committee sessions are held per year,
and a number of working group meetings are convened as required.
From the scientific viewpoint, I have had the privilege to be assisted by a team of excellent experts who
have prepared outstanding data for each meeting on a variety of complex issues. Also the members of ENGL
itself, as well as participating colleagues from other Commission services, have always contributed actively
so that each  meeting was of an outstanding technical level.
The effort required for managing these meetings is also considerable. Particularly off-site meetings such
as in Varna (Bulgaria) or Prague (Czesch Republic) were very challenging to organize, but my staff did in
all cases an excellent job.
This document will show that ENGL is a coherent structure of top-class researchers who appreciate
working together and who are assisted by an excellent administrative support team.
I give my thanks  to all,
The European Network of GMO Laboratories
Guy Van den Eede
Chairman ENGL
Head of Unit, Biotechnology and GMOs
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The level of expertise and the international profile of
the ENGL have been acknowledged by the European
Commission, and in particular by DG SANCO, by
appointing the JRC — in collaboration with ENGL — as
the Community Reference Laboratory (CRL) in the context
of Regulation (EC) 1829/2003 on GM food and feed. This
CRL nomination is a “JRC first”. Its tasks include:
• reception, preparation, storage, maintenance and
distribution to national reference laboratories of
the appropriate positive and negative control
samples,
• testing and validation of the method for detection,
including sampling and identification of the
transformation event and, where applicable, for
the detection and identification of the transfor-
mation event in the food or feed,
• evaluating the data provided by the applicant for authorisation for placing the food or feed on the
market, for the purpose of testing and validation of the method for sampling and detection,
• submitting full evaluation reports to the European Food Safety Authority (EFSA).
The Community Reference Laboratory shall also play a role in dispute settlements between Member
States concerning the results of the tasks outlined in this Annex.
Further guidance to the operation of the CRL can be found in “Commission Regulation (EC) No 641/2004
of 6 April 2004 on detailed rules for the implementation of Regulation (EC) No 1829/2003”, which has been
co-drafted by the JRC and DG SANCO.
In November 2003 the ENGL Plenary Meeting finalised the document “Definition of minimum performance
requirements for analytical methods of GMO testing”. This document provides information about the method
validation process and its requirements with respect to
the regulatory compliance and control purposes. In
2004, with the support of four experts of ENGL, detailed
procedures have been laid down for the operation of
the CRL. Since April – as requested by the Community
Legislation – the CRL is fully operational.
For more information: http://gmo-crl.jrc.it
From ENGL to CRL
http://gmo-crl.jrc.it
http://engl.jrc.it
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Over the last few years, the Joint Research Centre has undertaken substantial efforts to integrate Enlargement
countries’ experts and organisations in its activities and projects.
The JRC Enlargement Action consists of a number of integrated activities aimed at stimulating collaboration
within research projects, hosting temporary staff at the JRC premises, organising workshops and training
courses, and disseminating information and enhancing communication with the Enlargement Countries.
The objective of the JRC Enlargement Action is to support the EU Enlargement policy and contribute to
the widening of the European Research Area. It deals, in particular, with complex scientific and technical
aspects underpinning EU legislation that are presently handed by the JRC. It covers a wide range of areas,
such as environment, health, food, renewable energy, chemicals, agriculture and nuclear safety. Most
activities are carried out in close co-operation with the relevant policy DGs.
The JRC Enlargement Action resulted in training 1200 experts in 2002, hosting 80 researchers at the JRC
institutes (August 2003) and establishing some 300 new partnerships with scientific and technical organisations
in the Enlargement Countries.
The JRC can play a catalyst role in the continuous integration of AC/CC in the European Research Area.
Notably the JRC can via joint submissions for FP6 projects, in which it acts as partner at equal footing,
promote the participation of CCs in integrated projects and other FP6 instruments. Since January 1st 2003,
the JRC has been involved in 160 research proposals submitted to various FP6 calls. Over 70% of these
proposals include one or more partner(s) from Enlargement country(ies).
Support to the Enlargement Action
Giancarlo Caratti
Head of the JRC Enlargement Unit
Stakeholders’ conference and inauguration ceremony
held in Prague on 29th April 2004
On April 29th 2004 in Prague (CZ) the ENGL welcomed 24 laboratories from Accession Countries and
as such aligned well with the process of Enlargement. With this, the total number of members has reached
71 laboratories, and the Steering Committee has 26 permanent members.
Press conference with two of the
czech ENGL representatives
The ENGL chairman with representatives of the 24 GMO laboratories
from Accession Countries who officially signed the ENGL agreement
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ENGL Steering Committee
Yves Bertheau
INRA PMDV DMO / FR
Patricia Bonner
State Laboratory / IR
Hermann Broll
Bundesinstitut für
Risikoewertung (BfR) / D
Anna Christodoulidou
General Chemical
State Laboratory / GR
Andrew Damant
Food Standard Agency / UK
Eugenia De Andrade Silva
Direccão-Geral de Proteccão
 das Culturas / PO
Andreas Heissenberger
Umweltbundesamt (UBA) / A
Marina Miraglia
Istituto Superiore di Sanità
(ISS) / IT
William Moens
Institute of Public Health / B
Emile Laurensse
The Food and Consumer Product
Safety Authority / NL
Peter Stephensen Luebeck
Danish Plant Directorate / DK
Erkki Vesanto
Plant Production Inspection
Centre / FI
Guy Van den Eede
Chairman
Rupert Hochegger
Austrian Agency for Health
and Food Safety (AGES) / A
Arne Holst-Jensen
National Veterinary Institute / NO
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Peter Siekel
Institute for Molecular Biology of
Solovak Academy of Sciences / SK
Barbara Tudek
Institute of Biochemistry and
Biophysics Polish Academy
of Sciences / PL
Merike Kelve
National Institute of Chemical
Physics and Biophysics / EE
Jaroslava Ovesna
Resarch Institute of Crop
Production / CZ
Klara Dallmann
Godollo Agricultural
Biotechnology Centre -
Environmental Biosafety
Research Institute / HU
Nadia Lanzon
Environment Protection
Directorate / MT
Ieva Rodze
State Veterinary Medicine
Diagnostic Center (SVMDC)
of Food and Veterinary Service / LV
Jana Zel
National Institute of Biology / SLO
Vacloovas Jurgeleviceus
National Veterinary Laboratory / LT
Ioannis Ioannides
Agricultural Research
Institute / CY
Newcomers from Accession Countries
Note: Members of the Steering Committee not pictured here are Marcel Bruch (Ministère de la Santé, LUX),
José Juan Sánchez Sáez (Centro Nacional de Alimentación, SP), Martin Sandberg (National Food
Administration, SW)
ENGL Steering Committee
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Austria
• AGES Landwirtschaftliche Untersuchung und Forschung Wien
(LWVIE) / Wien
• AGES - Lebensmitteluntersuchung und Forschung Wien (LUVIE)
/ Wien
• Umweltbundesamt GmbH (UBA) / Wien
Belgium
• Ministry of Social Affairs, Public Health and Environment.
Scientific Institute of Public Health (IPH). Service of Biosafety
and Biotechnology / Bruxelles
• Ministry of Small Enterprises and Agriculture. Centrum voor
Landbouw Onderzoek (CLO). Department Plantengenetica en
-veredeling / Melle
• Ministry of the Walloon region. Agricultural Research Centre
(CRA). Quality of Agricultural Products Department / Gembloux
Cyprus
• Agricultural Research Centre / Nicosia
• State General Laboratory / Nicosia
Czech Republic
• Institute of Chemical Technology / Prague 6
• Research Institute of Crop Production / Prague 6
• National Institute of Public Health / Brno
• State Veterinary Institution Jihlava / Jilhlava
• Czech Agriculture and Food Inspection / Brno
Denmark
• Ministry of Food, Agriculture and Fisheries. Danish Plant
Directorate (PDIR) / Lyngby
• Danish Veterinary and Food Administration. Institute of Food
Safety and Nutrition (FDIR) / Søborg
Estonia
• National Institute of Chemical Physics and Biophysics / Tallinn
• Agricultural Research Centre / Saku
Finland
• Finnish Customs Laboratory - Tullilaboratorio / Espoo
• National Veterinary and Food Research Institute (EELA) / Helsinki
• Plant Production Inspection Centre (KTTK ) / Loimaa
France
• Institut National de la Recherche Agronomique (INRA). Centre
de Versailles Unité de Phyto-pathologie et Méthodologies de
la Détection de Versailles (PMDV). Equipe de Méthodologies
de la Détection des OGM (MDO) / Versailles
• Direction Générale de la Concurrence, de la Consommation
et de la Répression des Fraudes (DGCCRF). Direction des
laboratoires. Laboratoire de Strasbourg / Illkirch Graffenstaden
• Laboratoire National de la Protection des Végétaux (LNPV)
d’Orleans / Fleury les Aubrais
• Groupe d’Etude et de Contrôle des Variétés et des Semences
(GEVES), laboratoire BioGEVES / Surgeres
Germany
• Behörde fur Umwelt und Gesundheit (BUG) / Hamburg
• Bundesinstitut für Risikobewertung (BfR) / Berlin
• Chemisches und Veterinäruntersuchungsamt Freiburg (CVUA)
/ Freiburg
• Robert Koch-Institut (RKI) / Berlin
• Bayerisches Landesamt für Gesundheit und Lebens-
mittelsicherheit-Außenstelle München Molecular Biology
Greece
• Ministry of Finance. General Directorate of General Chemical
State Laboratory Food Division (GCSL) / Athens
• Seed Testing Station / Maroussi
• Institute of Agrobiotechnology (INA). Centre for Research and
Technology. Hellas, Thermi / Thessaloniki
• Ministry of Agriculture. General Directorate of Animal Production
Inputs. Section of Feedingstuffs / Athens
Hungary
• National Public Health Center - National Institute of Food
Hygiene and Nutrition / Budapest
• Godollo Agricultural Biotechnology Centre - Environmental
Biosafety Research Institute / Godollo
Ireland
• Ministry for Finance. State Laboratory / Dublin
• Ministry for Agriculture, Food and Rural Develop-ment. National
Crop Variety Testing Centre / Dublin
Italy
• Istituto Superiore di Sanità (ISS). Laboratorio alimenti / Roma
• Istituto Zooprofilattico Sperimentale Lazio e Toscana (IZSLT).
Dipartimento di Virologia e Biotecnologie / Roma
• Ente Nazionale Sementi Elette. Laboratorio Analisi Sementi
(ENSE) / Tavazzano (Lodi)
Lithuania
• National Veterinary Laboratory / Vilnius
Latvia
• State Veterinary Medicine Diagnostic Center (SVMDC) of Food
and Veterinary Service / Riga
Luxembourg
• Ministere de la Santè. Laboratoire National de Santé. Division
du Contrôle des Denrées Alimentaires (LNS) / Luxembourg
Malta
• Environment Protection Directorate / Valletta
The Netherlands
• Rijks-Kwaliteitsinstituut voor Land- en Tuinbouwproducten
(RIKILT) / Wageningen
• Inspectorate for health protection and veterinary public health
- Keuringsdienst van Waren (KVW) / Amsterdam
• Nederlandse Algemene Keuringsdienst (NAK) / Emmeloord
Appointed Laboratories
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Participants in the 3rd ENGL Plenary Session, held in Barza (Italy) on November 2003
 Norway
• National Veterinary Institute. Section of Food and Feed
Microbiology (NVI) / Oslo
• Norwegian Food Control Authority (SNT) / Oslo
Poland
• Plant Breeding and Acclimatisation Institute Radzikow / Blonie
• Institute of Biochemistry and Biophysics Polish Academy of
Sciences / Warsaw
• Institute of Genetics and Animal Breeding Jastrzebiec Polish
Academy of Sciences / Wolka Kosowska
• State Sanitary - Epidemiological Station Tarnobrzeq / Tarnobrzeg
• The National Veterinary Research Institute / Pulawy
Portugal
• Instituto de Biologia Experimental e Tecnológica (IBET) / Oeiras
• Instituto de Tecnologia Quimica e Biologica
• Direccão-Geral de Proteccão das Culturas (DGPC). Laboratorio
de controlo de Materiais de Multiplicaçao de Plantas / Lisboa
• Instituto Nacional de Engenharia e Tecnologia Industrial (INETI)
- Departamento Biotecnología / Lisboa
Slovakia
• Institute for Molecular Biology of Slovak Academy of Sciences
/ Bratislava
• State Veterinary and Food Institute / Dolny Kubin
• Central Control and Testing Institute of Agriculture / Bratislava
Slovenia
• National Institute of Biology / Ljubljana
• Agricultural Institute of Slovenia / Ljubljana
Spain
• Agencia Española de Seguridad Alimentaria / Madrid
• IRTAGen - Servicio de Análisis Genéticos / Cambrils (Barcelona)
• Centro Nacional de Biotecnología. Campus de la Universidad
Autónoma de Madrid (CSIC) / Cantoblanco (Madrid)
Sweden
• National Food Administration (SLV) / Uppsala
United Kingdom
• Food Standard Agency (FSA) / London
• Department for Environment, Food and Rural Affairs (DEFRA).
Central Science Laboratory (CSL) / York
• Scottish Agricultural Science Agency (SASA) / Edinburgh
• Laboratory of Governmemnt Chemist Ltd (LGC) / Teddington
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View from the industry
Brussels, 13 May 2004
Dear Dr Van den Eede:
I am writing in response to your 
enquiry about a short contributio
n for your Annual
Report.  With the recent applicati
on of Regulations EC Nos 1829/2
003, 1830/2003 and
641/04, the EU legislative framew
ork for GMOs nears its completio
n. At all stages of the
development of this legislation, we
 have called for centralised proced
ures - a key criterion
for success in implementing this co
mprehensive legislation in a practic
able and transparent
manner.
In accordance with the GM Food an
d Feed Regulation EC No 1829/2003
, we are therefore
pleased to note that the European 
Food Safety Authority (EFSA) has b
een designated as the
authority responsible for the safety
 assessment for GM plants, and th
e Biotechnology and
GMO Unit of the Institute for Hea
lth and Consumer Protection at th
e Commission’s Joint
Research Centre’s (JRC) as the C
ommunity Reference Laboratory
 (CRL) with primary
responsibility for the validation of 
detection methods for GMOs.
We consider that the JRC, assisted
 by a consortium of laboratories in
 the EU Member
States referred to as the European N
etwork of GMO Laboratories (ENG
L), has a major role
in coordinating and establishing t
he standardised procedures for th
e validation of GMO
detection methods.  We are fully s
upportive of the important role tha
t the JRC has played
in accomplishing the work done t
o date. As a key stakeholder in thi
s process, EuropaBio
and its Member Companies note th
at there is still much to do and look 
forward to developing
our collaboration with the JRC/EN
GL to ensure that this particular as
pect of the regulatory
process is managed in a pragmatic
, cost-effective and timely manner.
Yours sincerely,
Simon Barber
Director, Plant Biotechnology Unit
Av. de l’Armée 6  B1040 Bruxelles
  •  Fax: (32.2) 735 49 60
mail@europabio.org  • www.euro
pabio.org
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View from a researcher
Lisbon, 19 July 2004
Dear Dr Van den Eede:
I am writing in response to the request for a contribution for the European Network ofGMO Laboratories (ENGL) Annual Report about the “View from a researcher on theNetwork”.
Since the Network exists researchers note a strong progress towards:1) the cooperation between experts of different but related areas on the GMOfield. Experts from the Food/Feed and from the Seed sectors together withexperts from the Biotechnology and GMO Unit of the Institute for Health andConsumer Protection at the Commission’s Joint Research Centre’s (JRC) as theCommunity Reference Laboratory (CRL), following the Commission Regulationsand Recommendations have been supervising several distinct highly importantsubjects in order to strengthen the implementation, on the field, of the “GMpolicies”;
2) the development of methods through the participation in several Europeanfunded projects;
3) the validation and harmonization of methods amongst the network laboratories.They also note the need to upgrade the capabilities and capacities, mainly of theenforcement laboratories of the competent authorities, through their accreditation undera suitable accreditation (or certification) system, in order to improve the legal basis foreffectively functioning on the GMO control. Related to this subject, researchers consideredcrucial all the assistance given by the JRC in coordinating training courses and consultation.Researchers fully supported all the recent initiatives of the JRC in the acceptance of thenew labs from the recently integrated Member States in the Network and in accomplishingcollaboration with all involved researchers.
All together look forward to improve this great collaboration
Yours sincerely,
Eugénia de Andrade Silva
PhD, Responsible Researcher of the Laboratory for theCharacterization of Plant Propagating Material
Quinta do Marquês  2780-155 Oeiras  •  Fax: (351) 214 464 099
www.dgpc.min-agricultura.pt
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To a representative of the (up to know) smallest EU -
Member State, ENGL has been a motivation booster to
implement GMO detection laboratory in my Country.
The high quality of the scientific discussions, set up in
a mediterranean atmosphere, generates (scientific)
inspirations, highly appreciated in my home Country.
Gilbert Moris, Luxembourg
I have got new information used for establishing GMO control system in Czech Republic;
fresh information about the progress in e.g. sampling strategy, reference materials etc.;
the opportunity to participate in KELDA Project; to opportunity to meet experts from other
Countries and to share experience and information about the accreditation of GMO laboratories.
Katerina Demnerova, Czech Republic
ENGL is an important body through which MS and Accession
Country get an access to updated information about technical and
legislative issues concerning GMO and it’s also a platform to set
up or improve detection methods, and to disseminate them in EU
Countries.
Barbara Tudek, Poland
ENGL is a very important and good platform to discuss all
the problems in the field of GMO analysis and therefore a tool
for the harmonisation of the analysis and the reglement of the
results of GMO analysis.
Klaus Pietsch, Germany
Each speciality within GMO testing (e.g. feed, food and seed)
has different ways of viewing the problems associated with GMO
testing. ENGL provides a forum, which allows these specialists to
formulate methods and solutions to find a way forward for the benefit
of all.
Vincent Mulholland, UK
Introduction on GMOs
The participating laboratories of the ENGL are involved in the analysis of plants and their seeds
to check if they have been produced by genetic engineering and they analyse food and feed to
check if they have been derived from genetically modified crops. This work is technical and very
complex, therefore we will try here to explain what a GMO is and what makes it different from
a traditional crop, how analysis is being done and why it is so important that we have robust and
efficient methods in place that can be used across the EU — and beyond — in a harmonised
manner.
Genetically modified organisms, or GMOs, differ from all other organisms by the fact that they
carry pieces of genetic information (DNA) that originates from another species with which they
would not be able to cross in nature. Whereas normal sexual propagation can only occur between
closely related species, this does not apply to GMOs: the creation of a GMO may bring together
pieces of DNA from totally unrelated species, e.g. DNA may be taken from a bacterium, a virus,
or may be taken from a human or animal cell and put into a crop plant.
Insect resistance maize for instance, has been obtained by inserting a piece of DNA that has been
cut out of a bacterium into a traditional maize variety. This bacterium, known as Bacillus thuringiensis,
produces a toxin which, when ingested by larvae of certain insects, destroys their stomach and
kills them. Sprays are being sold that contain high concentrations of this bacterium to use in order
to combat insects. But once sprayed, the bacteria do not stay long on the plant leaves, with wind
and rain soon eliminating them. Therefore, researchers have inserted this characteristic into maize
plants, which is now marketed in the EU as well as in most parts of the world.
To obtain a GMP, DNA from another, non-related species must be introduced into the genome
of the host plant. For practical applications, the “foreign” DNA must remain stable, and be heritable,
i.e. it should be passed to all offspring.
In most instances the foreign DNA is inserted into plant cells that are cultured in laboratory dishes
after their cell walls have been removed. These cells are known as “protoplasts”.
Once a protoplast has been obtained, the process of introducing DNA into them can begin. There
are two main ways for stable insertion of foreign DNA into protoplasts. The first
one uses a bacterium, named Agrobacterium tumefaciens as an intermediate delivery
vehicle. In nature, A. tumefaciens colonises a wide range of plant hosts, often
transferring a piece of its own DNA into the host plant cells where it is incorporated
into the hosts genome and causes the plant to produce sugars of nutritional value
for the bacterium. The consequences of these events are commonly observed in
nature as swellings, or galls, on host plants. Scientists have modified this system
for the purpose of plant genetic modification and have applied it successfully to a
wide range of plant species, excluding however agronomical important crops such
as cereals. Cereals however may be genetically modified by mechanical means,
such as the injection of foreign DNA or the application of ballistic guns that shoot
DNA into the plant nucleus.
Once single plant cells are modified, they are grown in tissue culture, until finally,
entire plants can be regenerated. Since all offspring originate from a single cell,
the term “clone” is used correctly. The clones all contain the same piece of foreign
DNA.
Examples of the ‘first generation’ of GM crops include pest resistant Bt cotton, which — as explained
above — uses a soil bacterium (Bacillus thuringiensis) that produces toxins against insects. Also
herbicide-tolerant soybeans which have been developed to resist non-selective herbicides, including
glyphosate (mainly by using genes isolated from micro-organisms) belong to this group. So far,
the vast majority of commercially released GM crops are first generation applications that mostly
aim at providing on-farm benefits.
What is the difference between a traditional crop plant and a genetically modified crop?
How are genetically modified plants (GMPs) made?
First generation GMOs or ‘input trait’ crops
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A ‘second generation’ of GM crops aims at providing new value-enhanced or ‘output’ traits that improve
the quality of the product to food producers or consumers. They may improve nutrient content, flavour,
processing or storage characteristics. Examples include high oleic acid soybeans that contain less saturated
fat than conventional soybean oil, high sucrose soybeans that improve food quality by improving taste and
digestibility, and potatoes resistant to browning.
A ‘third generation’ of GM crops may be used for industrial or medical purposes to replace or enhance
existing production systems. Examples include biologically-based plasticisers and lubricants, pharmaceuticals
(e.g. production of vaccines in crops), and nutraceuticals or ‘functional foods’ (where food crops contain
pharmaceutical properties such as disease-preventing micronutrients). An example of an existing nutraceutical
is a strain of rice modified to produce pro-vitamin A, which can assist in reducing the incidence of blindness.
Another example is canola oil with high beta-carotene content.
Safety has utmost priority and therefore, genetically modified food, food additives, animal feed and processing
auxiliaries are subject to comprehensive safety tests before they can enter the marketplace. Applicants for
a marketing license are obliged to show, on the basis of tests that have been conducted, that the products
in question do not entail any risk to humans, animals, or the environment.
Whereas a product can only be approved for marketing when considered as “safe”, GM plants need to be
monitored after their marketing approval and eventual effects on the environment and on human and animal
health need to be spotted. In addition, modern food production — particularly in case of food and feed
produced from GMOs — need to be traced from the site of production (the farm) to the site of consumption
(the fork). Finally, food and feed derived from GMOs (or containing GMOs such as yoghurt containing
genetically modified Lactobacillus) — need to be labelled.
The need to monitor, to trace and to label, in other words the need to verify the presence and  amount of
GMOs in agricultural crops, and in products derived thereof, has generated a demand for analytical methods
capable of detecting, identifying and quantifying either the introduced DNA, or the protein(s) expressed,
in transgenic plants. In addition, for certain types of GM food such as vegetable oils with altered fatty acid
profile, chemical analysis, such as chromatography and near infrared spectroscopy may be a complimentary
or alternative tool for GMO detection.
In general this process consists of three different steps (see figure one in annex):
Detection (screening of GMOs), in order to gain a firsthand insight into the composition of the food and
agricultural product. Analytical methods for detection must be sensitive and reliable enough to obtain
accurate and precise results in all control laboratories, which can be achieved through inter-laboratory
validation.
Identification to reveal how many GMOs are present and, if so, if they are authorised within the EU (or
other countries with regard to their regulations). A prerequisite for the identification of GMOs is the availability
of detailed information on their molecular make-up. Molecular registers that, along with the scientific data,
contain the necessary data (confidential) for control authorities to design appropriate identification methods
are essential to fulfil this task. The European Commission, Joint Research Centre is in the process of setting
up such a database, for exclusive and private use by EU National Competent Authorities.
Quantification, in order to determine the amount of one or more authorised GMOs in a product or seed
lot, and to assess compliance with the threshold regulation. For this approach it is necessary to get a better
understanding of DNA/protein degradation during processing and of the robustness of the analytical methods.
The European regulatory system relies upon the availability of validated analytical methods. The objective
of validation of an analytical GMO method is to demonstrate that the successive/combined procedures of
sample extraction, preparation, and analysis will yield acceptably accurate, precise, and reproducible results
for a given analyte in a specified matrix. Depending upon the intended purpose of the analysis, i.e. qualitative
screening or quantification, different validation parameters have to be evaluated.
Second generation GMOs or ‘output trait’ crops
Third generation GMOs
Safety assessment
Tracing, monitoring and labelling
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Method validation is a lengthy process, which, according to international standards, involves at
least twelve different laboratories. It is also a process in which different players have different
responsibilities, e.g. the notifier is responsible for submitting an optimised method to the method
validator, but subsequently is no longer involved in the process. Currently, no GMO is allowed
for marketing if there is no validated method available to control authorities.
This work represents the core of activities of the European Network of GMO
Laboratories.
Every new GMO requires a new analytical method. In addition, control
samples need to be available for control authorities, because they need to
interpret the results of an unknown sample, with a positive and a negative
control sample. The JRC’s Institute for Reference materials and measurements
is the world’s first for this production.
To summarize, the genetic modification of organisms provides fascinating
prospects for a large variety of application in industry, agriculture as well
as in many other domains. Careful assessment as well as control and monitoring
is essential. It is the role of ENGL to show to governments, developers,
industrialists and most of all to the general public that such control, although
being difficult, can be carried out and is organised throughout the EU in a
harmonious way.
Assay individual
ingredients
GMO quantification
operational procedures
to comply with the food and feed labelling regulation in the EU
GMO detection Positive
YesGMO identification
Negative
No
Assay individual
ingredients
GMO present?
Are they authorised?
Labelling required No need for labelling
>0.9% <0.9%
Tolerance
<0.5%
Illegal
>0.5%
Must be labelled? Can be placed on the market?
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Simplified scheme of the
It is very important for me to discuss on subjects related to the
GMO control problems, with people working in the same area.
Marianne Monsted Jorgensen, Denmark
ENGL is a wonderful network of people having discussions at
a high level of expertise. The diffusion of information within the
Network, the exchange of views and the communication of scientific
results, aim at making feasible the enforcement of the European
legislation, relatively to GMOs.
In the same time it also contributes to harmonise the approaches
of control laboratories all over Europe.
Gilbert Berben, Belgium
For me ENGL is a space in which the Members can share
experiences, exchange ideas and discuss technical issues.
Within the ENGL we can also update information on
method validation, CRMs production, research projects progress
and regulation issues.
David Zhang, France
E - “European”- Europe? Enlarged Europe? – Worldwide recognition!
N - “Network” – Network? Sometime like a family, but most of the
times a real (hard) working group
G – ”GMO” – Our common interest, covering many aspects, leading
to hot discussions
L – “Laboratories” – The places where we have to go back to, after
we had the pleasant and interesting meetings at the JRC...
Andreas Heissenberger, Austria
ENGL: Point of reference! In the past many activities were
going on in as many different labs in Europe.
Now there is a well-coordinated organisation that can prevent
the duplication of efforts and greatly facilitates the exchange of
views and experiences.
Esther Kok and Henk Aarts, The Netherlands
Overview of major activities
Labelling requirements for authorised GMOs
Under Regulations (EC) 1829/2003 and (EC) 1830/2003, products consisting of or containing
GMOs, and food or feed containing, consisting of or produced from GMOs, or containing
ingredients produced from GMOs, are subject to labelling requirements.
Exemptions apply to traces of authorised GMOs in products intended for direct processing
(Article 7 of (EC) 1830/2003) and to foods containing material, ‘which contains, consists of or
is produced from GMOs in a proportion no higher than 0.9% of the food ingredients considered
individually or food consisting of a single ingredient’ (Article 12 of (EC) 1829/2003).  The presence
of such material must be adventitious or technically unavoidable. The same exemptions apply
to feed. See also Article 47 of (EC) 1829/2003 establishing lower thresholds in certain cases.
A new Directive setting thresholds for the adventitious presence of GM
seed in conventional seed lots is expected to be introduced in the near future.
The Directive will be accompanied by a Regulation on a protocol for sampling
and testing of seed lots.
Biological factors in the quantitation of genetically modified material
Currently used methodology for quantitative measurement of the presence
of genetically modified material is based on Real Time PCR technology.  In
GMO quantitation RT-PCR is used to measure the number of copies of a
target DNA sequence, specific to the GMO of interest, relative to the number
of copies of a species-specific DNA sequence.  However the reference
materials used for calibration are usually based, not on copy number, but
on a % wt. of GMO material, or DNA extracted from such material.  Moreover,
the results have to be expressed in terms of  % GM material (material containing, consisting
of, or produced form GMOs) on an ingredient basis, in order to determine compliance with the
legislative thresholds.  This is demonstrated graphically below.
Thresholds
MU
L1
GM analysis
E.g. Determination of % GM material in a food ingredient
Calibrant
Test Method
Expression of result
L2
% wt GM material
IRMM CRMs % wt GM material / total wt
Extraction of stds, samples; PCR
Calibration (Ct vs log Copy number)
Output: Copy number ratio (sample)
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The relationship between % copy numbers and % by wt. of GM material is influenced by complex
biological factors such as phenotypic expression, zygosity and, in the case of heterozygous seed material,
whether the transgenic source is male or female.
If the relationship between % wt GM material and copy number ratio in the calibrant (L1) is different
to the relationship between the copy number ratio and % GM material in the sample ingredient (L2), then
there exists an added biological uncertainty over and above the analytical measurement uncertainty (MU).
As the uncertainty in the final result needs to be taken into account in assessing compliance with legislation,
it is important to consider these issues.
Moreover, traceability1, the property of a result of a measurement, or the value of a standard, whereby
it can be related with a stated uncertainty to stated references through an unbroken chain of comparisons,
is a requirement under ISO/IEC 17025. It helps to ensure comparability of results in space (between
laboratories) and in time.
In the case of seeds it is possible to use a statistical approach, based on multiple sub-samples and the
use of qualitative PCR, to assess compliance with thresholds that are defined on a % seed basis. This approach
is highly reliable, but is considered both time-consuming and costly. If RT-PCR is applied to determine %
GM seeds, then similar issues as those discussed above have to be considered.
Barza Meeting
The first discussion group meeting on thresholds in the context of the GM legislation was held at the
ENGL Plenary meeting in Barza, Italy, in November 2003. The meeting discussed the interpretation of the
legislation and the biological issues.  While there are no simple solutions to the biological questions, it was
generally agreed that it was important to have full knowledge of the origin of genetically modified material
used in preparation of reference materials, and that it was important to state the method and the reference
material used when reporting results.
1. ISO Guide 30 and VIM (International Vocabulary of Basic and General terms in Metrology)
Patricia Bonner
State Laboratory
Dublin (IR)
Hermann Broll
Federal Institute for Risk Assessment
Berlin (G)
Marc De Loose
Centre for Agricultural Research
Melle (B)
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Vallidation in the light of ENGL
Before a GMO detection and quantitation method can be introduced into use by control
authorities it should be validated in a collaborative trial with several participating laboratories.
In a validation study, evidence that the method consistently meets the requirements for the
intended application is obtained. A method, which is used for control purposes, should be
properly validated to assure reliable testing results. In the past, European GMO testing laboratories
have faced serious problems to obtain methods and necessary reference materials for GM testing.
Therefore, it is natural that one of the main activities of the ENGL has been to improve the
availability of validated methods for the testing.
In the last year, major progress was made thanks to the to the new regulations — in particular
to the GM Food and Feed Regulation (EC) 1829/2003. For each GM authorization, the applicant
has to submit — among other things — a method for detection, sampling and identification of
the transformation event. The Regulation nominates the Joint Research Centre as the Community
Reference Laboratory for the GM Food and Feed with the main task of  validating the methods
submitted by the applicant. The Regulation further states that the JRC will be assisted in this task
by the ENGL. The ENGL assistance consists mainly of the scientific assistance
and technical support to the CRL. In particular, the ENGL laboratories
are the preferred partners in the collaborative trials organised by the CRL.
Validation process
In principle, validation of analytical methods including GMO detection
is a very important step and it is the absolute requirement according to
international standards before it could be used for control purposes. It is
the process of establishing the performance characteristics and limitations
of a method and the identification of influences which may change these
characteristics and to what extent. The main goals of validation are that
the test results obtained with a certain method are accurate and precise,
the methods used end with a result which is comparable with a result
achieved with the same or a different method.
Specific performance parameters have to be tested before a method could be accepted as
validated. Only the analyte under investigation should give a positive respond. In case an event
176-specific method is used, the result has to be negative, if only events other than event 176
are present in the sample. To decide if a method is “fit-for-purpose” the sensitivity needs to be
analyzed, otherwise it could happen that a method with a limit of detection (LOD) of 2% is used
to meet a 1% threshold. A negative result obtained with this procedure would probably lead
to a wrong interpretation and decision by e.g. QS manager or competent authorities. Furthermore
the trueness and precision have to be determined. The closeness of a result to a true GMO
content is analyzed by using reference material. The deviation between the mean value and the
true GMO content is typically expressed in terms of bias. Whereas the closeness of individual
determinations with the same method and the same sample describes the precision of the method.
If it is determined in-house it is expressed as the “repeatability” of the method. In case the same
method is applied to a defined matrix in different laboratories it is called “reproducibility”. It
is a obvious that the latter one is very time and cost-intensive and will only be done if all other
characteristics of the method under investigation are given satisfactory results.
As shown in the figure below, the usual process of “full”-validation could be divided into
three parts:
1) the method development and optimization in a single laboratory;
2) a pre-validation study with a few laboratories (3-4) to get an indication, if the
method works in different labs, and finally
3) the step in which the method is tested in a collaborative study with at least 12
laboratories to determine the precision under reproducible conditions.
All performance characteristics described above lead into a “fully-validated” method which
will be the absolute requirement for food and feed control purposes. Moreover, the EN ISO/IEC
Validation
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17025 standard describes general requirements for the competence of testing and calibration laboratories.
Specifically, the need to use only validated analytical methods is described as a prerequisite to perform tests.
In contrast to method validation, proficiency testing is often mentioned, but the aim is totally different.
By participation in a proficiency testing study a laboratory could demonstrate their competence to carry
out GMO testing. In proficiency tests each individual laboratory can use any method established in the lab
which is fit-for-purpose to detect and/or quantify the analyte under investigation.
ENGL Working Group Validation
The year 2003 was a very intensive period for the ENGL working group validation. In the authorization
context, there is a need for a clear approach, firstly, for accepting a method for the validation process and,
secondly, for the minimum performance requirements, which a method should fulfil in a validation study
in order to be accepted as fit for control purposes. In addition, the applicants need clear guidelines of what
is expected from them, e.g. what is understood with a method and what are the matrices to be considered.
During the year 2003 the ENGL elaborated the approach for the validation within authorization context.
The work was initiated during the first ENGL Working Group meeting “Definition of minimum performance
requirements for analytical methods” (Ispra, Italy, January 16-17, 2003). Thereafter, comments from the
ENGL members were incorporated into the document on several rounds.
The draft document was made available in the ENGL web-pages, and scientific and technical comments
from all interested parties were invited during the period 1.7/15.8.2003. Several comments mainly from
all the major companies as well as governmental and research organisations were received. All the comments
received were reviewed in ENGL Steering Committee meeting in September and considered in-depth in
an ENGL Working Group meeting dedicated to the topic (Ispra, Italy, October 20-21, 2003). The approach,
which is currently used by the CRL was accepted in the ENGL Plenary meeting in October 2003.
Towards the end of 2003, the ENGL experts were invited to express their interest in the work in a CRL
expert group to establish the operational procedures of the CRL. This work commenced in early 2004
—and is a very good example of the ENGL assistance function to the CRL. Currently, a CRL advisory panel
consisting selected ENGL expects is continuously assisting the CRL in scientific questions.
Development of the Modular Approach for Validation
The so called modular approach for method validation has been developed and discussed within the
ENGL in 2003. The original idea has been presented and published by Arne Holst-Jensen from the National
Veterinaruy Instittue of Norway. The idea is that a method refers to all the methodological steps needed to
analyse the notified (or otherwise relevant) material. For a particular material this may include, for instance,
the methods for DNA extraction and the final quantification in a PCR system. In such a case, the whole
chain from extraction up to the PCR-method (or equivalent) constitutes a method, but the different method
parts can be validated separately (i.e. modular validation). The idea of the modular method validation is
that each method or protocol can be validated separately, and once validated, can be combined with other
modules in a flexible manner.
The modular approach is incorporated to the CRL validation scheme, supported by the CAN approach
of standardization and it is tested and developed further in research collaborations. For instance, an EU
integrated project proposal COEXTRA (coordinated by Yves Bertheau from INRA)  contains a considerable
element in further developing the approach —and GM testing in general.
Bt11 sweet maize collaborative study
During the 2003, the ENGL and the JRC concluded the first full validation study which was carried out
for the GM authorization purposes. The collaborative study was carried out to test the performance of a
quantitative event-specific method to detect and quantify the Bt11 transformation event in sweet maize.
The method validated had been developed by the National Veterinary Institute of Norway and INRA, France,
within the EU shared cost action project QPCRGMOFOOD. The 14 participants of the validation study were
members of the ENGL from nine different European countries. The materials needed in the study (GM and
non-GM DNA as well as the method-specific reagents) have been provided by Syngenta.
In addition, the pre-validation studies for the validation of detection methods for the GA21 maize and
NK603 maize were initiated during the 2003.
Hermann Broll
Federal Institute for Risk Assessment
Berlin (G)
Janna Puumalainen
JRC-B&GMOs Unit
Ispra (I)
28
Introduction
A GMO analytical service is carried out to gain information regarding the composition of a
large body of target material. In contrast, a very small amount of material is subject to the
analytical procedure. As a consequence, the sampling processes used to prepare the analytical
samples are of paramount importance to ensure reliable and informative
analyses.
Although guidelines defining sampling strategies for quality and
purity analyses are available and currently adopted for GMO surveys,
their suitability for GMO detection is questionable because of their
stringent statistical assumptions with respect to the possible distribution
of the contaminants. Indeed, most of these guidelines recognize that
the procedures are not effective in the sampling of non-random
distributions. Whilst lot homogeneity can be assumed for seed lots,
traditionally subject to stringent protection methods for limiting genetic
contamination and to smaller upper lot size limits to facilitate mixing
and homogenization, it cannot be unconditionally assumed for grains
and bulk commodities, which are more prone to segregation during
transportation and handling.
Yet, given the lack of suitable statistical approaches to define sampling procedures appropriate
for situations where standard statistical models cannot be applied, currently available sampling
protocols continue to be used without verification of their assumptions. Nevertheless, when
sampling is executed to check for compliance with legislation requirements, it is of crucial
importance to ensure a high degree of confidence that the survey is accurate and that the sampling
error is as small as possible.
Provided that understanding distribution patterns in kernel lots is a pre-requisite to develop
and recommend suitable sampling plans with respect to European GMO legislative requirements,
ENGL has initiated, and currently is carrying out, different initiatives to gain the scientific
information necessary to support the achievement of harmonization of sampling plans in the
different Member States.
Research Projects
ª KeLDA (Kernel Lot Distribution Assessment) is an ENGL collaborative pan-EU research
project, coordinated by the Biotechnology and GMOs Unit, IHCP-JRC, designed to
investigate the distribution of GM contaminations in soybean
grain lots imported in the EU from different countries outside
the EU. As a case-study, KeLDA represents the first project carried
out to assess the real distribution of GM materials in soybean
grain lots imported within Member States, and it is the first study
to provide real data on this issue. KeLDA results will allow to
assess the distribution of GM material in raw bulk materials,
to evaluate suitability of currently adopted sampling strategies
for the detection of GM material in bulk lots, and to provide
recommendations for implementing sampling strategies to ensure
effective sampling. Up to date, 12 soybean lots have been
sampled and analyzed for the presence of GM material. A
preliminary analysis of the results obtained so far indicates that
distribution patterns do vary among lots and do show
heterogeneity.
ª A new approach to investigate the effects of different levels of heterogeneity on the
accuracy and suitability of different sampling plans for the detection of GM contaminations
within kernel lots was developed. The approach is based on a two-step procedures that
Sampling
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allows first, to create virtual kernel lots with different levels and distribution patterns of GM contaminations
and second, to test different sampling strategies. The flexibility of the model allows the simulation of
large kernel lots without imposing any constraint on the distribution of GM contaminations. As a result
of this flexibility, the effects of different levels of heterogeneity can be assessed, through simulations,
on the accuracy and suitability of different sampling approaches for the detection of GM particles
within kernel lots.
ª To support and further develop the approach described above, an exploratory software - KeSTE
(Kernel Sampling Technique Evaluation), designed to evaluate sampling strategies as function of lot
properties in case of non-random distribution of contaminants was developed and distributed to ENGL
members. The software is available free of charge on the ENGL website. KeSTE allows the evaluation
of different sampling strategies on both simulated lots, with user-defined characteristics (exploration
of hypothetical scenarios), and on real lots. This first version of KeSTE should be considered a preliminary
one, meaning that some part of the code must still be optimized, and other must be still added. This
is not due only to the state of development of the software, but also to the state of development of
the conceptual models behind KeSTE, which are continuously evolving as a consequence of the use
of the software itself. As a result, the software target users are researchers with some experience in
sampling theory and practice. When the conceptual models will be consolidated, we can foresee the
development of a derived, user-friendly version targeted to a more applied rather than explorative
evaluation of sampling.
Technical Advice
Among ENGL priorities there is also the provision of internal support and external advise on focused
issues to regular network committees and expert working groups on an ad hoc basis. In particular, during
the last year of scientific activity, ENGL experts have provided technical advise to
1) the DG SANCO “Working group on seed legislation, sampling and detection” for the definition of a
protocol for the sampling and detection of GM seeds in seed lots and
2) to DG ENV and DG SANCO for the preparation of the Commission Recommendation on technical
guidance for sampling and detection of GMOs and material produced from GMOs or in products in
the context of the Regulation (EC) nº 1830/2003 and
3) to CEN with respect to concerns raised by ISO regarding the compatibility of sampling plans for
foodstuffs proposed by CEN (discussion paper CEN/TC 275 WG 11 N 0059) with other internationally
adopted sampling protocols.
Reduction of sampling error
Repesentative sample
Sampling protocol
Lot
Free of distribution assumptions
Claudia Paoletti
JRC-B&GMOs Unit
Ispra (I)
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According to the EC regulations food or food ingredients containing GMOs (Genetically
Modified Organisms) must be clearly labelled. Certified Reference Materials (CRMs) are
indispensable tools to accurately determine the concentration of GMOs used for the production
of food. In 1997, the Institute for Reference Materials and Measurements (IRMM) developed,
produced and certified the first ever reference materials for GMOs to support reliable and
comparable GMO identification and quantification. Until now three generations of matrix GMO
CRMs for various GMO events in maize and soybeans have been produced in accordance with
ISO Guide 34: Roundup Ready® soybeans (IRMM-410S), Bt-176 maize (IRMM-411R), Bt-11
maize (IRMM-412R), MON810 maize (IRMM-413), GA 21 maize (candidate IRMM-414) and
NK603 maize (candidate IRMM-415). In general CRMs matrix CRMs like the GMO powders
are designed for the verification of the correct application of standardised methods. Several of
the powder GMO CRMs were also used for the development and validation of screening and
quantification methods for GMO food. In addition the IRMM is currently developing methods
to certify pure DNA CRMs suitable for the calibration of DNA-based measurements.
The certification of the GMO concentration in the matrix CRMs
is based on the dry mass of GMO powder in dry non-GMO powder.
During the certification procedure the gravimetrical values are verified
by application of commonly used GMO quantification methods
targeting the transgenic DNA or the transgenic protein.
Thorough control of the raw material is the first production step
of a GMO CRM and is of high importance for all fields. GMO and
non-GMO raw materials need to be of highest purity with a defined
genetic composition.
Contamination during the production process is avoided using
targeted production equipment. Another crucial point is the grinding
of the seeds to a particle size allowing homogenous mixing. For the
production of the 3rd generation of GMO CRMs with high DNA/protein
quality a dry-mixing technique was developed. The well-characterised
GMO powder is diluted stepwise with non-GMO powder during this production step. The
powders with different GMO concentrations are afterwards bottled under appropriate conditions.
Verification measurements for the GMO concentration and homogeneity and stability controls
are carried out.
Homogeneity and stability are of utmost importance for the certification of such reference
materials in order to ensure validity of the certificate for each bottle of a batch throughout a
defined shelf-life. These characteristics ensure comparability of a certain CRM batch. Traceability
to SI systems or other stated references are essential for the international comparability of CRMs
and to ensure that they can be reproduced. For the GMO powder CRMs traceability is ensured
with the gravimetrical approach used and the characterisation carried out.
Certified Reference Materials
Stefanie Trapmann
JRC-IRMM
Geel (B)
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ENGL has formed a very good floor that allows an efficient
action of individual laboratories. Due to high level research,
validation studies and information dissemination better
approaches can be employed to solve gmo ? (vedi form) topics.
Especially for Czech laboratories ENGL is a rich source of
experiences, that are applied to improve control process.
The possibility of participating in the ENGL projects
(e.g. KELDA Project) is a great opportunity.
Jaroslava Ovesna, Czech Republic
ENGL has been a place of exchange of information,
experiences and discussion and a seed of new ideas, all in
a warm and friendly atmosphere.
The importance of this for our daily work is not
measurable.
Teresa Crespo, Portugal
ENGL is a network that demonstrates the strength of working together
to achieve an end result. To date the activities of the members, we have
been able to bring about a co-operative working forum that seeks to
promote excellence in analytical competence and to share experiences in
GM analysis and regulation throughout the EC.
The community has granted ENGL legal status to pursue its activities
in recognition of the significance of this work and it is evident that
Member States will benefit from its continued operation.
Sarah Oehlschlager, UK
To our perception the ENGL is acting as a scientific and technical network.
This was felt mainly by:
 1) the exchange of information within its members: we appreciated the organisation
of different working/discussion groups. They had a great contribution for the excellent
annual results also obtained by our laboratory
 2) the participation in European projects
3) the exchange of experiences with experts from the Accession Countries  was also
relevant: this leaded us to bilateral co-operation projects.
Eugenia De Andrade Silva, Portugal
Interview
During the 3rd Plenary Session of ENGL, held in Barza (Italy) in November
2003, an exchange of views on ENGL took place between William Moens
[WM] (Institute of Public Health, Brussels) and Katerina Demnerova [KD]
(Institute of Chemical Toxicology, Prague), moderated by Rossella Speroni [RS]
(Joint Research Centre, Ispra). At that time Accession Countries were not ENGL
full members but observers.
R.S.  How do you perceive the ENGL Network?
K.D. Being a member of the ENGL is really
important to my country. We joined it two years
ago, after receiving the official invitation to
participate in a meeting of the Network. Together
with Bulgaria and Poland, we were the only
socialistic country in the Network at that time.
Getting into the ENGL has been a first step
towards a new way of working, because we
had the opportunity to learn from other
colleagues how to study and checking the GM
food, as, in my country, we did not have a
proper network of laboratories to do so.
Regarding the exchange of information and
support within the network, I would like to say
that Guy is very open. He gave Kamila, a Czech
researcher working now in our laboratory in Prague, the opportunity to work for
nearly ten months in his laboratory in Ispra and to learn the techniques of sampling,
which to me is very important for the estimation of GMOs. I believe it is of the utmost
importance to connect all laboratories working on GMOs in my country, so as to
share all information my laboratory receives as a member of ENGL; for this reason
I am waiting for the accreditation that is foreseen for next year.
R.S.  Accreditation is a relevant matter for GMOs laboratories. Could you explain something
more concerning accreditation?
W.M.  Accreditation is an interface between laboratory activity and the regulatory framework.
In my country, analysis of data are acceptable only if they are produced by accredited
laboratories. All other data are interesting but not legally useful. For enforcement, data
has to be defendable in court. As a consequence, in Belgium, the top priority is to first
establish a network of accredited labs and afterwards one of non-accredited laboratories.
For my laboratory, accreditation has been the key to becoming a valuable partner of
the Belgium Authorities. We have several Authorities and several regulatory frameworks
as well. These Authorities do not all have the same perception. Food safety is more
in the context of food quality, quality management of the food chain and environmental
monitoring. The ENGL priority is the food chain and the regulation deriving thereof.
Environmental aspects are of less importance. From the cost point of view connected
to the experimentation phase, this entails a totally different approach. Accreditation
is the only way to actively contribute to the success of the role the CRL, which has
been given by the EU Regulation in the field of GM foods and feeds. In Belgium, the
existing ISO7025 standard provides for an interaction between laboratories using
standard procedures and institutions so that the information and  administrative data
could be well maintained and predictable. The ENGL will help the work of accredited
labs and the CRL.
K.D. We have experience with accreditation as for microbiology and classical microbiology
for the testing of food. But if we compare it with the accreditation for GMO testing
the base could be the same but the practical method is completely different and much
more difficult to establish. Accreditation is the more important step to take before
being able to work in combination with other laboratories. At the very beginning, in
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CZ there were no accredited laboratories. Nowadays, you have to be accredited
otherwise you will not be accepted and cannot do anything without it. No
companies will accept your data.
W.M.   Accreditation is the only way to get data that could be defended
in court and traced back from the quality point of view. Scientists who
can be hired in public labs are not of the type you could find in top
competitive research and we therefore have to adapt the technology
in use. It must be very simple to manage, predictable and these
people must be able to use it safely from the result point of view.
So, accreditation is also a disciplinary step to make a lab
predictable from the management viewpoint, it is the only
way to be sure that the results and correct. Accreditation is
also a safety system for the quality of the data and their
reliability. If the CRL sends control samples with new
primers they would need to know whether this
work is in accordance with procedures, regulations
etc. Trust is vital, as, if something is found
to be wrong one has to rely on the
other’s judgement  otherwise it will
create total confusion. Accreditation
is a guarantee that the standards of
quality of the work are respected.
Accreditation is a way to ensure good
laboratory practice.
R.S.   In 1999, what was the idea lying behind a meeting
among a number of CAs as the ENGL was intended to be at that
time?
W.M.   Regulation No. 258/97 provided for a threshold to prove adventitious
contamination of food by GMOs. In that context there was a clear need
for measurement. But what? How? For which level of confidence? It was not
obvious at all. Some people around the table, like Bertheau, Broll and myself, “the starters”, concluded
that if we were not able to co-ordinate in one way or another and get the authorities to sustain us
it would have been impossible to comply with the regulatory requirements. It seems the words we
exchanged at 2 o’clock in the morning in front of a bottle of grappa were convincing. Six months
later not only the CAs but also the internal co-ordination of the Commission was working: a miracle.
Everybody was laughing at me when, during Mr Busquin’s speech at the Inauguration Ceremony of
ENGL in Brussels last year, I said that it was something to write in the Guinness Book of Records.
R.S. Would you have ever figured out that the ENGL could become the network it is now? What were
your expectations?
W.M. No expectations. We are people working for administrations, therefore, we know what the real life
is. Communication is of great importance. Maybe we wanted to express our needs and be understood.
This phenomenon was repeated during each meeting. Now the people in our group have become
friends, they communicate with each other and they are respectful towards each other, this helps.
It helps in speeding up the process. In 1999, we could have never imagined that after 3 years we
would have had such means, ideas, vision, unity, and convergence of practical ideas. These are not
academic discussions but day to day problems in life.
K.D. I also appreciated this environment a lot. You have a lot of committees in the group. At an academic
level one talks a lot but at the end of the day you often do not have a clear conclusion. Nothing to
pass on to my lab people. On the contrary, when I go back to my lab after having taking part in an
ENGL meeting, I am able to improve the work of my staff and my communication with other labs.
That is totally unique.
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W.M. This is the European spirit: people converging to build something together. One feels it in the daily
work. This is no philosophy. No politics or ideologies but day by day practice.
K.D. And it does not matter where the person is coming from. It is open (here she speaks about Norway
and the fact this country is not yet a full member of the EU). It does not matter. There is no difference
between member and non-members. Non-members need to attain the same level of knowledge.
Maybe not totally the same but as  close as possible. We should be able to interact on the same level
and to exchange our know-how trustingly. ENGL has a very wide perspective and looks into the
future.
W.M. Unique to the ENGL dynamic, indeed. In the structure of the EU, laboratories are not partners of
the political decision or political vision. Policy executives of the CAs or companies have no voice
in technology and the way it is applied. In the ENGL it’s exactly the contrary. All these labs get
instructions from the top; they have the horizontal ability to talk to each other to define commonalties
and problem, to formalise this in a readable way, to communicate with the outside and go to the
headquarters to deliver the message to the authorities. This is new! It does not happen in the
medical, pharmaceutical and environmental area. It is the first time, I guess, unknown labs can
speak to each other and communicate to “the high and mighty”. We are building a validation
network. We apply research to genetics. We have a lot of genetic markers. These might change
but the technology remains the same. We build the network not only of experts but also of
accreditation experts and network accredited experts. This is a unique tool in the world. Our Union
has an original validation system, which is highly powerful not only for GMOs but also for all kind
of genetic markers.
K.D.   (She speaks about the great opportunity to apply for FP6 projects as another way of interacting, even
if W.M. refutes that the miracle of ENGL is not necessarily reproducible elsewhere). I like the idea
that people work together on the same project with the same aim.
R.S.   Something about the importance of the Reference Materials (RMs).
W.M.  RMs have to be evaluated from both a scientific point of view (their role in the scientific context)
and the regulatory one (their importance, the responsibility of the companies
to deliver good and appropriate RMs).
K.D.   According to our experience, when we started the accreditation
process we realised that to validate methods accurately we did need
appro-priate RMs. In CZ, Monsanto and some other companies,
which are producing GMOs, are asking for permission to place
these products on the Czech market. To do so, they have to declare
that they will be providing the sequences of the relevant primers.
Obviously this will be strictly confidential but they will have to
guarantee that they will supply the labs with the appropriate
control materials. It has happened previouslythat we have bought
RMs which were not accurate and therefore we did not get
the right results. So sampling, in my mind, is very important.
It is a crucial step of our accreditation process. It is vital to
estimate correctly transgenic DNA.
W.M.  Do you think that ENGL has been able to influence the
companies to better define RMs?
K.D. I think so. I think ENGL could serve as a benchmark and
could play the role of an inspector. In this way, the companies
feel under pressure. For instance, American companies
that would like to place on the market
products derived from GMOs are
now aware of the fact that
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they must respect fixed rules, they must respect the advice from ENGL and the opinion of the labs
ENGL has brought together.
W.M. I agree. I am not against the companies but in the interest of the consumers, we need predictable
GMOs, predictable laboratories, we need transparency. This is a key issue to which a large amount
of our funding is being committed.
K.D. Exactly. One of our major challenges is to protect the public against the spreading of wrong information
and products. People’s perception is very important above all in the GMO field. If you tell a lie once,
people will lose their trust in you.
W.M. Credibility is the number one prio-rity. This is a really important message to deliver. If autho-rised,
GMOs are perceived as products deriving from top technology, as they are indeed, also the top
regulatory management and top information ensuing thereof are a symbol of their quality. GMOs
are certainly the best controllable and traceable products existing nowadays. GMOs are traceable
by default because of their genetic modification. The public may have not believed in this at the very
beginning but I am sure that the birth of ENGL added a piece to this puzzle and will certainly improve
the credibility of these unknown products.
K.D. In the future, I think GMOs will play a crucial role in food and non-food fields. This is why we have
to build  a trustworthy system to avoid any fear from the consumers’ part. They must feel confident,
they must say: “I can eat this, it is safe. There is a good control system. If the product has been placed
on the market it must be safe otherwise it would not be commercialised”.
W.M. It is again evident that we need robust reference materials. For the company, the CAs and ENGL.
K.D. In connection to RMs, I would like to have more information on the plasmid RMs.
W.M. In December 1999, at the ILSI meeting in BXL, I proposed that the analyte of traceability in case of
GMOs were the genetic markers most of the time (or epitopes more rarely). In such a way that the
analyte could be purified and become a kind of canonical RM from the genetic viewpoint, we would
have access to a bank of RM from the genetic / matrix point of view. Therefore, we started to clone
all genetic markers involving traceability. The advantage of such an approach is that the cloning and
availability of RMs are totally controllable by the CAs. They can synthesise the markers by themselves,
they can obtain the plasmids very rapidly with the guarantee of purity and from the validation point
of view. This is totally independent from the good or bad will of the companies or providers. Well,
this in theory… In practice, if someone wants to use these genetic markers they have to be commutable.
It should be demonstrated that they could replace classical RMs. We are still trying and demonstrating
that it is possible to interchange classical RMs, certified RMs, genomic DNA and plasmids. But it
is a matter of months not years! It is ENGL philosophy to use validated stuff only (i.e. materials and
methods). We have to make a proficiency testing of these plasmids used as quantitative or qualitative
RMs and then we have to deal with them and distribute them to the ENGL community and to all
those who surround the ENGL. But this is still under discussion.
K.D. Any foreseen trials?
W.M. Our plan is to, first of all, build a model/set of plasmids that could be used in proficiency testing,
and / or for identification, and/or for quantitation. We now know that we can combine all three
aspects within one genetic marker. Granted that the amplicon of Real-time PCR is the way to detect,
identify and quantify at the same time, all genetic markers are available to do so. Now we are working
on some of them and a small network of seven laboratories has been constituted. Amplicons are
being collected and cloned in my laboratory. We can now use plasmids all in the same way and
deposit them in an official collection system. We should provide the JRC with the set of DNA
(December, January 2004 max.) and we have to set up the project for the proficiency testing, what
the test will be, the time frame available to answer to the relevant questions etc. The lab itself could
be also tested for its ability to screen and not to quantitate. For example, if I give you a mixture of
GMOs, how many weeks, days, hours will you need to exactly list these GMOs one by one? Which
ones and in which proportion? Is there one exceeding the fixed threshold? This is the real challenge!
By using the plasmids you can play with their combinations! In this mixture we have seven GMOs:
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which ones? And in this one you do not know their number and nature. Just do it.
You have two weeks.
K.D. This is interesting. Is it possible, in your mind, to make it in two weeks?
W.M. I do not know! We have to demonstrate if this is realistic and feasible. We have to
realise that the screening is the number one step to face for all labs. Due to the
threshold regulation we have been investing a lot of time in Real-time PCR. But
screening!!! Would serve to obtain the highest results with the minimum investment
of money. And when you find something that is above the 0.5% threshold you will
go for Real-time PCR or  pass this work to another laboratory within the networkso
that we do not all invest on the same activities. We are in the process of preparing
a report for the end of March 2004 so that when the regulation will enter into force
the plasmid analyte will be ready. We do have to provide professional standards.
Therefore, either IRMM in Geel will instruct how to produce, control, certify and
distribute or we will have to design other types of mechanisms to use them. It could
also be format for Real-time PCR. We could publish calls for tenders asking companies
to provide plates, buffers plasmids etc. so that we will just have to have the primers
and test the DNA.
K.D. You have to be accredited, too.
W.M. Yes, of course. In my accreditation system we are already using plasmids.
K.D. You mentioned you have a bank of plasmids.
W.M. We have a bank with ninety plasmids in total so far. Fifteen are usable for screening
and identification purposes. Three could be employed for sure in Real-time PCR.
K.D. This is going quite fast! You did a very good job!
W.M. Yes, but we have very unstable means to develop this further and for that reason I
am looking for companies to finance us. I do not know who is going to pay for all
this! So perhaps we could maintain other stable activities such as cloning. You can
clone amplicons and this can be useful in terms of validation of the method. They
provide the method. We can provide the plasmid directly from what we have got.
K.D. Have you been able to find any company so far?
W.M. No… I do not think that companies will ever develop the reference genes we are
talking about, because, even if they could develop what they want, we are the ones
producing the reference system and validating it.
K.D. I was just wondering whether they could support you in the beginning…
W.M. Frankly, I prefer to dispose of less money but not to have someone who can influence
me on the choice of amplicons, in the cloning which have to strictly comply with
the regulatory dossier. The companies do not have any of these dossiers. We only
can check that the amplicons we are using are written in them. Afterwards, it will
be up to the Commission to decide whether to make this information publicly
available. In this case, yes of course, we will have to protect our rights, too! This is
public money, public funding so we are forced to publish but once the plasmids are
available everybody could take them. Monsanto, for instance, could buy all of them
and ask to be paid for them! So far there is no way to protect from these scenarios
arising.
K.D. This is not easy.
W.M. You see, traditionally, in practice, the companies have the power to control the RMs
and this may lead to clashes with the CAs in the future. What will be their role? This
should be clearly stated. Is this a political decision or a matter of quality of the
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procedure? If we intend to frame the use of plasmids inside the activities of accredited labs belonging
to the network this should be made clear.
K.D. This is tricky. Who will take this responsibility? In my opinion it is part of the Commission’s duties
to support and defend the role of ENGL.
R.S. How do you imagine the future of ENGL?
W.M. So, where are we going now? I think our top priority is to deliver to the outside through our websites,
through mails, attendance to conferences, scientific presentations and articles…
K.D. This is very important! Communication is very important! Not only among members but also with
all persons who might be interested. We have to spread information outside the network. Websites
might be very useful with this regard. They are a way to share experiences immediately. I would also
like to repeat the experience of the Varna meeting we had in September. It would be nice to involve
a wider number of representatives i.e. US, South America, China, Japan etc., but I can imagine it
would take a lot of time to organise such an event! Concerning the short term, we will host the
Inauguration Ceremony of ENGL for PECO countries next year. We are very proud that Prague has
been chosen as the venue of this important event and we will do our utmost to make it a success!
R.S. Some adjectives to define the ENGL?
K.D. Belonging to the network as full members will be very useful for us and will give us a lot of
opportunities to improve our daily work. We would very much appreciate becoming members of
the Steering Committee, if possible, in the future and would enable us to transfer knowledge and
experience to our countries. For example, so far only one soybean from Monsanto has been authorised
for placing on the market but cannot be grown. I do hope this situation will improve after our full
accession to the EU.
W.M. One thought, if you look at the financing system of the Commission in relation to RTD, minimal
resources have been allocated to us. A major part is allocated to the academies and industries.
Nothing for us. Academies are usually involved in basic research, development of new technologies
and their transfer to industries, which diversify their products accordingly. Whereas all we are doing
is completely different. We do not have the funding. The Commission does not seem to take us into
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William Moens during his speech at the Inauguration Ceremony of the ENGL in Brussels on 4th December 2002.
From left to right: European Commissioner Philippe Busquin, Kurt Van den Berghe (Commissioner’s Office),
Mr Moens and H J Buhk (Rki)
account. The truth is that we have serious scientific problems upstream and concerning
ENGL, there is no money for this project. This must be the responsibility of the
Member States. This is not subsidiarity. There are EU scientific problems and they
should be harmonised at EU level first and then at a local level. This is enforcement
but there is also an intermediate step: which is ENGL!
K.D. (She talks about the KeLDA project). The project is stopping because there is no one
to analyse the samples, which is peculiar because the project could be useful and
spread worldwide.
W.M. CRL and ENGL could also play a role in terms of connection between Member
States and scientific labs, accreditation, quality management, certification, referencing,
proficiency testing, validation etc, not only for control activities. This is missing at
EU level. We will never manage to keep the ENGL alive if there is no money to
finance training, workshops, scientific research. (Here he finishes talking about
microarrays and the huge investment this technology may require in terms of hardware
and software).
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The ENGL is a mixed top-team and I hope that the network
is able to stay on the ball, because the costs of reaction are
always higher than investments in action.
Rupert Hochegger, Austria
The participation in ENGL meetings has been extremely
useful for introducing
GMO testing in Estonia. It has also given important
personal contacts with colleagues from other labs..
Merike Kelve, Estonia
The experience has been positive. The ENGL allows to exchange
scientific information, to develop regulation provisions, to discuss technical
or practical problems and to be updated on different events regarding
GMOs.
It also helps a lot to have personal contacts with people in charge of
GMO in other Countries and institutions.
Almudena Rodríguez Sánchez-Beato, Belgium
It is a network of scientists concerned by the sampling, detection,
identification, quantitation of GMO seeds, commodities and ingredients
from the field to the dish and backwards. ENGL is the interface between
the scientists of the Commission and those from the enforcement and
associated laboratories. ENGL laboratories will apply the CRL validated
methods to the real market and disseminate their results.
William Moens, Belgium
ENGL is an important forum for me to participate in
discussions on GMO issues. It is important for me to participate
in the Validation group and the Kelda Project with the aim
to streamline my own laboratory. The discussions are always
fruitful.
Peter Lübeck, Denmark
Personal Experience
1 What is ENGL for your country?
2 What is ENGL for your professional life?
3 What is your personal perception/experience with ENGL?
The ENGL has become a very important platform for exchanging information between
authorities, scientists and other stakeholders in the last few years. This development was mainly
due to the energy Guy Van den Eede and his team at the JRC put into the Network but also
due to the fact that it offers the unique possibility to meet people from all over Europe (the
enlarged one!) with the same interest — analysis and research in the field of GMOs — on a
regular basis and discuss with them. I was asked, and it is a great honor for me to follow this
request, to write a few lines on my personal point of view regarding the ENGL.
1
As Austria is a small country, situated at the border of the old EU and right in the middle
of the enlarged Europe, having contacts to Western, Central and East European countries is
very important. This is not only true for the GMO business but for all areas. At least in the field
of GMOs the ENGL provides a unique information network, enabling the members to establish
contacts and developing common projects.
The number of GMO-laboratories in Austria is quite small, and though they are experienced
in carrying out analyses and are maintaining high level quality assurance systems, their research
capacity is limited. Another problem we are facing is, that though there is an intense exchange
between the laboratories, it is not that easy to reach a “critical mass” under this circumstances.
For control laboratories in Austria therefore it is absolutely necessary to establish co-operation
with laboratories from outside the country. The ENGL has become a major source for analytical
methods but also for background information exchanged during the meetings or via the bulletin
board. This information and co-operation does not only facilitate the control of GMOs for the
laboratories but also saves a lot of money for the authorities which otherwise has to be spent
in developing and validating analytical methods.
2
Becoming a member of the ENGL was a major step for my professional life and the
recognition of the Umweltbundesamt as an expert institution in the area of GMO-analysis.
Just one example: As mentioned above Austria has a strong relationship with some of the
enlargement countries. My institute is carrying out Twinning projects in the framework of the
EU PHARE program with the aim of assisting authorities in some of the enlargement countries
in setting up biosafety monitoring systems. Being a member of the ENGL (and the Steering
Committee) was one important factor in getting this projects, and is always a great help during
negotiations.
But not only for the application for projects having the ENGL “in the back”
has become a major point. I recognized, that the expertise of the
Umweltbundesamt and myself has been upgraded in the view of authorities
but also for NGOs and other stakeholders. Referring to the ENGL increases
the strength of arguments and the position in discussing analytical
possibilities and challenges.
To be member of the ENGL means for me to
have access to interesting projects, meeting interesting
people inside and outside the Network, and having
the chance to discuss my ideas with a number of
the best experts in Europe.
and the European Network of GMO Laboratories
Vienna
Landwirtschaftliche Untersuchung und Forschung (LWVIE)
Umweltbundesamt GmbH (UBA)
A u s t r i
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Lebensmitteluntersuchung und Forschung (LUVIE)
3When I’m thinking about the ENGL and the past few years this network has been existing, many positive
pictures come into my mind. It is hard to pick the right or “most representative” ones. As we have recognized
during our work within the ENGL sampling is one of the mayor challenges in the GMO business. To cover
the many and very heterogeneous aspects of the ENGL a large number of “samples” has to be taken from
the last years experience — and that would certainly be beyond the scope of this report. Therefore I’ll try
to pick just a few thought’s and events, hoping they’ll give some impression on my very personal view of
the ENGL.
The ENGL is some kind of big family. Though the involved laboratories are in various stages of development
(like children of different age), I have the feeling that knowing each other for a long time, working together,
and meeting at least twice year has brought all the people together. The common interest, a professional
respect but also the will to assist each other in solving problems in the laboratory are the key to the success
of the ENGL. Besides the professional level there always
questions asked during the breaks like “How are your
kids?”, “Have you already moved to your new house?”
or “Did you enjoy the skiing?”. I think this shows, that
there is also a personal interest that keeps this group
together.
The ENGL is a real network. Of course all the members
are experts and are highly qualified in their field of work.
But a group of experts, even if they are coming from all over Europe, is still not a “Network”. What is needed
to build up a network? First of all there has to be one to keep the net together. Than there are the people,
who build up the net. There has to be common goal. That’s the structure. But this structure has to be filled
with life. In my opinion within the ENGL we have a solid structure and a lot of people who give inputs,
discussing their ideas, developing projects – at short: who want to keep the Network alive. We have developed
a “corporate identity”. And therefore the ENGL lives.
Last not least I want to tell a story which happened during the conference about “The ENGL in an
Enlarged Europe” held in Varna, Bulgaria. After the conference dinner — as usually — a lot of discussion
was going on about projects, GMOs in general, and the position of the ENGL. I was lucky to be at a table
with our chairman, some other people from the network and two colleagues from Cyprus. Suddenly one
of these, in order to draw a picture on the position of the ENGL in the enlargement countries, said “You
know what? The JRC and the ENGL are the Mekka for the GMO laboratories!”. Our chairman was shocked
for a moment. Than he started to argue: to say such a thing overestimates the importance and puts much
to much responsibilities and pressure on the ENGL and on the JRC. We all (!) tried to convince him, that,
besides “Mekka” may be a little bit to religious, the statement was absolutely correct. I remember that we
discussed on this topic for hours and went to bed long after midnight. To get up the next day was terrible.
But for me, and I think for most of us sitting together this night, it was very a very satisfying and optimistic
discussion: to hear all people offering their support to the JRC, to hear examples of other enlargement
countries, and to hear so many arguments, why the ENGL is so successful and important. And that’s what
it is: THE centre of excellence for research, method development and validation for GMO analysis in Europe.
Andreas Heissenberger
Umweltbundesamt (UBA)
Austria
In my opinion within the ENGL we have a
solid structure and a lot of people who want
to keep the Network alive
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1ENGL is still a matter of careful interests and hopes in Belgium. But I do assist to a growing
curiosity of the big heads since the first ENGL achievements are starting to impact at several
decisional levels of many EU members.
2
Since 1999, ENGL is growingly a part of my professional life. As member of the steering
committee, I have to relay the questions from the Belgian authorities and associated laboratories
and those of our partners. I also have to adapt progressively my laboratory framework to the
norms and to the technologies harmonized in ENGL fora.
I was lucky to participate to the very early 1999 discussions that
initiated the ENGL project. Since, I never stopped to commit myself in
this project.
to Working group of the CODEX Alimentarius and of CEN/ISO aiming at
defining normative guidelines for the detection and quantification of GMOs in
foodstuff. Berlin-DIN was certainly the place where the future ENGL bricks of
the “modular approach” have been designed: common concepts and vocabulary
has been conceived by people from allover the world. This tremendously helped to
provide the network with a common communication interface. Afterwards and as a feedback,
the ENGL work has improved the achievements at the CEN and ISO levels. ENGL meetings
have become a place to test ideas and methods. This is very exiting and stimulating. Presently,
ENGL is also a multidisciplinary source of
scientific consultancy for the establishment
of the Community Reference Laboratory
defined by the new GMO regulations. ENGL
work will not be finished with the institution
of the CRL. At the contrary, the CRL will
very soon starts to establish the scientific
and methodological references for hundreds
laboratories of the enlarged EU. Exploring the applicability of reference methods is certainly
the big strength of the network: a huge amount of research in food and environmental
technologies is consequently in front of the ENGL laboratories.
I’m pretty confident that ENGL and the forthcoming CRL are going to build a new
framework useful for the consumers, the industry and the authorities allover the world. CRL-
ENGL is no less than a new major reference for a more predictable market. ENGL is apparently
perceived as such since it becomes critized in the scientific litterature, a very good signal
that it is taken seriously.
My hope is that our colleagues and friends outside the EU will join the game and help
to improve the technologies and strategies to scale down the overheads and uncertainties
linked to any new growing framework .
In the meantime, I enjoy not only the European and pioneering atmosphere of ENGL but
also the privilege to work with highly motivated people.
William Moens
Institute of Public Health
Belgium
Brussels
Institute of Public Health (IPH)
Melle
Gembloux
Agricultural Research Centre (CLO)
Agricultural Research
Centre (CRA)
and the European Network of GMO Laboratories
B e l g i u
m
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ENGL meetings have become a place
to test ideas and methods.
This is very exiting and stimulating
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On the 4th of December 2003, the European Network of GMO Laboratories (ENGL) was consolidated
following the Inauguration Ceremony and the official signing of the agreement. Commissioner Philippe
Busquin, Director General Barry Mc Sweeney, IHCP Director Keens Van Leeuwen and representatives of
44 European Laboratories were present. Along with the Inauguration Ceremony, a stakeholder’s conference
as well as the first official ENGL plenary meeting took place with 74 participants. Cyprus was present in
all three meetings as an observer.
ENGL has been set up to create a forum for EU and EEA
to collaborate on sampling, detection, identification and
quantification of GMOs. Through the three plenary meetings,
the steering committee meetings, two GMO training courses
and a stakeholders’ meeting for an Enlarged Europe during
the last one year of its life, ENGL has achieved its goals.
The characteristic of every such meeting is the brainstorming
taking place among experts. The results of every meeting
are disseminated to all members and a vivid discussion
always follows via Internet. ENGL also assists new member countries such as Cyprus to set up and continuously
develop the technical infrastructure necessary for the practical implementation of the body of EU law.
Cyprus became full member of ENGL in April 2004 along with the other nine new Member States. Even
though at that stage Cyprus was only an observer, it has always received full benefits and help, as if it were
a full ENGL member. The help that Cyprus receives to harmonize its approaches in the development,
validation and implementation of analytical methods for the identification of GMOs is important. The
assistance Cyprus received from ENGL during 2003 could be distinguished in the following different
levels:
Legislative Issues
In September 2003, the House of Representatives of the Republic of Cyprus
passed the Directive 2001/18/EC into a national law. I was one of the
experts on GMO issues along with two other colleagues who were called
by the House of Representatives Environment Committee to assist in tackling
the scientific aspects of the legislation. During the long discussions our
team remained in constant communication with different members of
ENGL who have experience on legislative issues in order to obtain feedback
on relevant aspects arising along the way. I should point out that the assistance
we received from the ENGL experts was very useful.
GMO Training
A colleague from the State General Laboratory (Ministry of Health) and my self attended a one-week
intensive training course on GMO detection methods – “The analysis of food samples for the presence of
Genetically Modified Organisms” held at the Joint Research Centre in Ispra, Italy. The course was offered
by the Biotechnology and GMOs Unit (Institute for Health & Consumer Protection, Joint Research Centre,
European Commission) in collaboration with the World Health Organization (Regional Office for Europe).
During the course we were acquainted with various laboratory techniques and methods and we attended
several scientific lectures delivered by experts. Overall I rate the training course as excellent.
At the last plenary ENGL meeting, it was agreed that the next extended training course on the analysis
of food samples for the presence of Genetically Modified Organisms will take place in Cyprus, next
September.
Agricultural Research Centre
State General Laboratory
and the European Network of GMO Laboratories
C y p r u
s
Cyprus became full member of ENGL in April
2004. Even though at that stage it was only
an observer it has always received full benefits
and help, as it was a full ENGL member
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Molecular Biology Laboratory (MBL)
The Ministry of Agriculture, Natural Resources and Environment has assigned the MBL at
the Agricultural Research Institute as the Competent Authority for technical and scientific
issues regarding Directive 2001/18/EC.
As the leader of MBL, I undertook the task of preparing the Laboratory for conducting
GMO analyses. This preparation included the following steps:
1. Developing infrastructure
2. Transfer of Know-how
3. Instrumentation
4. Laboratory accreditation
The close collaboration and support from the experts of ENGL guarantees the outcome
of this major and difficult task.
As an epilogue I would like to state that it is a privilege to be a member of ENGL as, during
the last year, I had the opportunity to meet a group of wonderful people and excellent scientists.
I was informed on all the latest scientific advancements regarding GMOs as well as being a
partner in an FP-6 project submitted by ENGL.
Ioannis M. Ioannides
Agricultural Research Institute
Cyprus
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1Norway is not a member of the European Union, although we have close collaboration with the EU
through the EEA (regulating legal and trade issues), Schengen agreement (regulating the free movement of
people between countries in Europe) and ERA (Research framework programmes like FP6). Through the EEA
there is extensive adoption of EU legislation and trade
agreements and rules in Norway.  This is frequently described
as a B-membership in the EU, because we have no direct
influence on the decisions taken by the EU while we have
to implement the results of many of these decisions. The
indirect influence coming from the participation in bodies
like the ENGL that are important suppliers of background
information for decision makers is therefore particularly
important for my country.  Here we have the opportunity
to present our own ideas and views, exchange experience
and know-how, and listen to and participate in the discussions without restrictions.  In the specific area of
GMO traceability, I believe our participation in ENGL offers the best possible facility to keep ourselves
updated, to provide scientifically based background information to decision makers, and to establish a
dialogue with the EU with particular relevance to GMO legislation.
2
Through the ENGL I have established, reinforced and continued scientific collaboration with some of
the greatest experts in the world regarding GMO traceability and detection methods. The level of the scientific
discussions is often in the international forefront, and I believe some of the most influential ideas
relevant to GMO traceability legislation, GMO detection methods, PCR based method validation,
GMO reference materials and implementation of GMO legislation by enforcement authorities
have been developed and/or shaped by the scientific environment made available through
the ENGL. As an active participant in most of the discussions in the ENGL it is not
surprising that this leaves me with the feeling of being truly influential, for which I am
very grateful.
While ENGL is a mix of experts on different aspects of GMO traceability, it
is my impression that the vast majority of delegates feel that this is a place
where the learning curve is steep while at the same time room is offered
for asking simple questions and receiving adequate answers. The ENGL
offers a very friendly environment, while at the same time keeping
focus on the business. Time spent with ENGL is rarely non-productive
time, and I always look forward to taking up the discussions with
my colleagues and what have often become good friends as
well. Personally, I believe that I have contributed one of the most
influential ideas to the international traceability debate through
the ENGL by strongly promoting the modular approach for
method validation and application. This approach as it is promoted
via the ENGL is a trueborn child of the creative scientific
environment offered by the ENGL, and would probably never
have matured without the ENGL.
Oslo
Arne Holst Jensen
National Veterinary Institute
Norway
National Veterinary Institute (NVI)
Norwegian Food Control Authority (SNT)
and the European Network of GMO Laboratories
N o r w a
y
3
We have the opportunity to present our own
ideas and views, exchange experience and
know-how, listen to and participate in the
discussions without restrictions
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1Slovenia is a small country, intensively establishing its biosafety framework. The detection
of GMOs is one of the important issues in this system, supporting the regulations on labelling
and traceability, as well as environmentally related concerns on GMOs. Since Slovenia is a
preaccession country, charring the experiences
and ideas with European Union members is a
very valuable possibility offered by ENGL.
During the last year also some of the EU
members of ENGL came in Slovenia as guests
in the workshops organized by National institute
of Biology together with the Ministry of
Environment, Spatial planning and Energy in
the frame of UNEP-GEF project. Their input and experiences shared with different stakeholders
were very important also as a support for decision making in establishing the whole system
on GMO traceability in Slovenia.
2
The ENGL network is a community of different profiles of people, working on routine
analysis as well as basic research on GMOs. The close interaction with them means exchange
of practical experiences in official control of GMO in different countries,
methods used, interpretation of the results, decision making experiences.
On the other hand there is a possibility for joining basic research efforts
and ideas, leading at the end to the establishment of more precise and
cost effective methods for detection of GMOs which will again be used
further on in official control in the whole food chain from the field to
the store shelves. For me this a rear opportunity to really work in an expert
group where the critical mass of knowledge is achieved, which makes
the group really effective and productive. So the cooperation in ENGL means
a great enrichment of my professional life.
As the Head of ENGL Guy Van den Eede said on one of these nice evenings after the whole
day meeting, that we are all one big family, I must say that I completely agree with him, that
it is not only profession and GMOs that we are sharing, but also the friendship among all
members. His efficient leadership, strong and focus ideas about the network, supported by
experienced members of the group, as well as consent from all members that he always try
to achieve are adding a lot to this filling. So my perception of the ENGL is that this network
is one of the best experiences I had in my professional life.
Ljubljana
Jana Zel
National Institute of Biology
Slovenia
National Institute of Biology
Agricultural Institute of Slovenia
and the European Network of GMO Laboratories
S l o v e n
i a
3
We are all one big family, it is not only
profession and GMOs that we are sharing
but also the friendship among all members
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